JLL Partners related stories
All articles and analysis
Advent in the lead to buy inVentiv for close to $4 billion: ReutersPrivate equity firm Advent International is in advanced talks to acquire inVentiv Group Holdings in a deal that could value the U.S. pharmaceutical research firm at close to $4 billion, including debt, sources told Reuters News.
- PE-backed Bioclinica buys Compass Research
Bioclinica has acquired Orlando, Florida-based Compass Research, a clinical research company that tests medications. No financial terms were disclosed. Bioclinica is backed by Water Street Healthcare Partners, JLL Partners and Ampersand Capital Partners.
JLL's Michel Lagarde appointed president of PatheonPatheon, a Canadian-born drug development and manufacturing services provider, has named Michel Lagarde its president. Lagarde joins the company from JLL Partners, the U.S. private equity that helped take Patheon private for US$1.4 billion /canada/2014/3/patheon-take-private-deal-closed-company-forms-part-of-jll-controlled-dpx/ in March 2014. The deal saw the business amalgamated with a subsidiary of DPx, formed by JLL and Royal DSM. Patheon, which continues to have offices in Canada, is now based in Durham, North Carolina.
- PE-backed Patheon appoints new president
Durham, North Carolina-based Patheon, a provider of outsourced pharmaceutical development and manufacturing services, has named Michel Lagarde as president. The appointment is effective immediately. Lagard has stepped down from Patheon's board of directors. Previously, Lagarde worked at JLL Partners where he was managing director for several of the firm's portfolio companies, which included Patheon.
- JLL Fund VII hits $1bn target
The fund has so far made three investments, with two in the aerospace industry and one in a building-related company.
- JLL Partners Fund VII raises $1 bln
JLL Partners said April 6 that its seventh fund closed at $1 billion. Investors of JLL Fund VII LP include Colorado PERA, Cal Regents, Montana, Travelers Companies and certain funds and accounts advised by Neuberger Berman. JLL’s prior fund collected $807 million in 2009. The New York private equity firm invests in sectors including aerospace, healthcare, building products, financial services, and business services.
- Loar Group buys General Ecology
Loar Group Inc, a portfolio company of JLL Partners, has acquired General Ecology Inc. Financial terms weren’t announced. Exton, Pennsylvania-based General Ecology develops and produces water purification and micro-filtration systems for commercial and business aircraft under the Versa-Pure® brand as well as the worldwide residential, restaurant, portable, marine and recreational vehicle markets under the Seagull® and First Need® brands. BlackArch Partners advised General Ecology.
- Carlyle promotes Wise to global health care head
The Carlyle Group has promoted Stephen Wise to global head of its health care team. Wise joined Carlyle in 2006 from JLL Partners.
New Jersey hopes to exit JLL Partners Fund V by NovemberState officials believe the New Jersey Division of Investment could finalize its sale of a $50 million stake in JLL Partners Fund V on the secondary market by November.
- PE-backed BioClinica buys Synowledge
BioClinica, which is backed by Water Street Healthcare Partners and JLL Partners, has acquired Synowledge. No financial terms were disclosed, Based in Miami, Florida, Synowledge is a pharmaceutical and biotech company.